BioMarin Pharma (BMRN) Misses Q1 EPS by 8c
Tweet
Share
E-mail
Get Alerts BMRN Hot Sheet
Price: $59.00 +2.88%
EPS Growth %: -34.0%
Financial Fact:
Research and development: 160.83M
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: -34.0%
Financial Fact:
Research and development: 160.83M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
BioMarin Pharma (NASDAQ: BMRN) reported Q1 EPS of ($0.26), $0.08 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $373.4 million versus the consensus estimate of $348.57 million.
For earnings history and earnings-related data on BioMarin Pharma (BMRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
- Winnebago Industries (WGO) Misses Q3 EPS by 11c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
